Cargando…
Augmented β-Cell Function and Mass in Glucocorticoid-Treated Rodents Are Associated with Increased Islet Ir-β/AKT/mTOR and Decreased AMPK/ACC and AS160 Signaling
Glucocorticoid (GC) therapies may adversely cause insulin resistance (IR) that lead to a compensatory hyperinsulinemia due to insulin hypersecretion. The increased β-cell function is associated with increased insulin signaling that has the protein kinase B (AKT) substrate with 160 kDa (AS160) as an...
Autores principales: | Protzek, André O. P., Costa-Júnior, José M., Rezende, Luiz F., Santos, Gustavo J., Araújo, Tiago Gomes, Vettorazzi, Jean F., Ortis, Fernanda, Carneiro, Everardo M., Rafacho, Alex, Boschero, Antonio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182854/ https://www.ncbi.nlm.nih.gov/pubmed/25313308 http://dx.doi.org/10.1155/2014/983453 |
Ejemplares similares
-
Pancreatic Alpha-Cell Dysfunction Contributes to the Disruption of Glucose Homeostasis and Compensatory Insulin Hypersecretion in Glucocorticoid-Treated Rats
por: Rafacho, Alex, et al.
Publicado: (2014) -
Metabolic memory of ß-cells controls insulin secretion and is mediated by CaMKII
por: Santos, Gustavo Jorge dos, et al.
Publicado: (2014) -
Endurance Training Inhibits Insulin Clearance and IDE Expression in Swiss Mice
por: Costa-Júnior, José M., et al.
Publicado: (2015) -
SAT-162 Hepatocyte Nuclear Factor-4α (HNF44α) as a Target to Treat DM
por: Jorge dos Santos, Gustavo, et al.
Publicado: (2019) -
ER stress in rodent islets of Langerhans is concomitant with obesity and β-cell compensation but not with β-cell dysfunction and diabetes
por: Omikorede, O, et al.
Publicado: (2013)